Korea Investment Partners

Established in 1986, Korea Investment Partners is a prominent venture capital firm headquartered in Seoul. With over three decades of experience, the company invests globally in innovative startups across various sectors, including technology, healthcare, and manufacturing. Notable investments include Kakao, Naver, YG Entertainment, and Didi Chuxing. The firm manages multiple funds with total assets under management exceeding US$1.8 billion.

Kim Jong -hyun

Director

Jihyun An

Principal of Venture Group 2

Shane Ang

Investor

In Jae Baek

Principal of Venture Group 1

Yer Hyun Baek

President

Haksung Chang

Managing Director and Head, PE

Yan Hao Chong

Principal, Singapore

Yeong Mok Gil

Managing Director

Kang Joon- gyu

Team Leader

Hudson Kyungshik Ho

Investor

Jingzhi Hu

Managing Partner

Mahn Soon Hwang

Investor

Man Soon Hwang

CEO

Joon Hyun

Managing Director

Sang Hyuk Jang

Principal

Chung Jeong-mok

Senior team manager

Leah Jiang

Investor

Joo Young Joo

Team Leader

Soon Ouk Jung

Executive Director of Venture Group 2

Seung-hi Kang

Principal

Kun Ho Kim

Principal

Jae Hong Kim

Managing Director

Hwa Young Kim

Senior Associate

Hwang Kim

Head of Management Relations Team

Dong Yeob Kim

Investor

Chang Ho Kim

General Manager

Minjun Kim

Judge

Yunjoon Kim Ph.D

Managing Director of Venture Group 1

Yong Jae Kim

Executive Director

Min Q Kim

Director

Hee Jin Kim

Director of Venture Group 1

SuChan Kwon

Senior Associate

Su Chan Kwon

Principal of Venture Group 2

Ji soo Lee

Director of Venture Group 1

Sang Jin Lee

Principal

Young Tak Lee

Principal

Sangwoo Lee

Managing Director

Michael Lee

Executive Director of Venture Group 1

Sangjoon Park

Investor

Min Sik Park

Managing Director

Deok Joon Shin

Director

Deok Jun Shin

Managing Director

Dong Hyun Song Ph.D

Executive Director of Venture Group 1

Benjamin Hyun Mok Song

Principal

Ping Wang

Associate Partner

Jerry Xu

Director and Principal

Clara Yoon

Principal

465 past transactions

Guhada

Series B in 2025
Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting European boutiques with domestic markets, including shopping malls and fashion vertical commerce. The company specializes in supplying high-demand luxury items and contemporary products, offering a diverse selection of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada enables customers to access genuine luxury products at competitive prices, enhancing the shopping experience for those seeking premium fashion items.

Asteromorph

Seed Round in 2025
Asteromorph is a startup dedicated to advancing artificial intelligence for scientific research. It develops an AI-driven platform that assists scientists in generating innovative ideas and designing experiments, aiming to expedite scientific breakthroughs and surpass traditional human-centered methods.

viACT

Series A in 2025
viAct is an innovative AI company that specializes in providing scenario-based vision intelligence solutions tailored for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Established in 2016, viAct has successfully implemented hundreds of deployments, utilizing its proprietary AI algorithms to deliver detailed insights into job sites. The company's suite of over 30 pre-built AI modules empowers stakeholders to enhance personnel safety, minimize accidents, optimize operational costs, and monitor compliance with environmental regulations. By tracking site activities and assessing safety measures, viAct plays a crucial role in improving efficiency and safety standards within the construction sector.

ActiveOn

Series B in 2025
ActiveOn, a company specializing in cosmetic materials and microcapsules, including preservative alternatives, spares no effort to share happiness with neighbors, with the objective that happy employees generate the greatest goods.

Doers

Series A in 2025
Doers is an influencer commerce platform that offers several services for connecting influencers and companies.

Raywatt

Series A in 2025
Raywatt is a startup focused on developing innovative medical devices for cardiovascular interventions. The company specializes in a health technology platform that utilizes laser-based imaging technology to enhance the diagnosis and treatment of cardiovascular diseases. Raywatt's offerings include optical coherence tomography (OCT)-based machine learning for fractional flow reserve (FFR) prediction, as well as catheter-based high-speed OCT imaging. These advanced imaging technologies provide healthcare professionals with high-speed and high-resolution tools to improve patient outcomes in the field of cardiology.

At Home

Series A in 2025
AtHome is a home lifestyle solution company which solves the hidden problems for the customers.

Healing Paper

Series C in 2025
Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

Gangnam Unni

Series C in 2025
Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medical information and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries. The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases. As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.

Apptronik

Series A in 2025
Apptronik specializes in developing humanoid robots designed for various real-world applications. Their robots are capable of handling tasks typically performed by humans, such as case picking, down stacking, trailer unloading, palletizing, sortation, and heavy lifting. This enables industries to address labor shortages, improve job satisfaction, and enhance efficiency.

Selta Square

Series A in 2025
Selta Square is a company specializing in AI-driven drug monitoring solutions. It employs artificial intelligence technology to offer comprehensive drug monitoring services, allowing pharmacovigilance experts to minimize repetitive tasks and focus on critical evaluations.

Eastern Edition

Series A in 2025
Eastern Edition is a furniture brand specializing in home decor products that blend traditional Korean aesthetics with modern design principles. The company manufactures a range of items, including stools, sofa chairs, mirror lounges, and ceramic sets, using natural materials like wood, rock, and metal. Each piece is crafted to balance form and function, allowing customers to add cultural depth and sophistication to their living spaces.

My Herb & Healthcare

Series A in 2025
MyHerb Healthcare proivdes a specialized analysis for nutritional supplements.

Raywatt

Series A in 2024
Raywatt is a startup focused on developing innovative medical devices for cardiovascular interventions. The company specializes in a health technology platform that utilizes laser-based imaging technology to enhance the diagnosis and treatment of cardiovascular diseases. Raywatt's offerings include optical coherence tomography (OCT)-based machine learning for fractional flow reserve (FFR) prediction, as well as catheter-based high-speed OCT imaging. These advanced imaging technologies provide healthcare professionals with high-speed and high-resolution tools to improve patient outcomes in the field of cardiology.

Value of Space

Convertible Note in 2024
Value of Space develops an online platform that provides accurate and efficient property valuations for all types of real estate. Its system offers market value estimates through advanced automated valuation models, benefiting real estate market operators.

Pin Therapeutics

Series C in 2024
Pin Therapeutics is a biotechnology company developing therapeutic products that target disease-causing proteins for immune diseases, cancer, and aging-related conditions. It employs protein degradation systems to break down these proteins.

Vibezone

Seed Round in 2024
Vibezone operates a fan-centered platform dedicated to K-pop entertainment. It connects fans with artists through innovative services like image archiving and IoT-enabled goods, enhancing the overall fan experience.

Hyperaccel

Series A in 2024
HyperAccel specializes in hardware solutions tailored for AI application development. The company designs AI-specific semiconductors, optimizing memory bandwidth usage and enhancing cost efficiency, thereby facilitating real-time task completion for businesses.

Twelve Labs

Series A in 2024
Twelve Labs offers a platform that empowers businesses and developers to analyze and interpret video content through multiple modalities like visual and auditory data. This enables the creation of intelligent video applications across industries such as technology, media, entertainment, and security.

Aldavar

Series A in 2024
ALDAVER provides incredibly realistic personalized surgical training models using innovative biopolymer materials that closely resemble human tissues and 3D printing technology.

The Blessed Moon

Series A in 2024
The Blessed Moon is a cosmetics brand that offers skin, face, hair, and body care products, including makeup essentials such as concealer, blush, eye shadow, lipstick, and eyeliner, for domestic and international customers. The company focuses on delivering beauty products aligned with current trends across skincare, makeup, and personal care categories.

Panmnesia

Series A in 2024
Panmnesia is a Korean startup specializing in the development of advanced chip technology. The company is dedicated to creating intellectual property surrounding a technology known as Compute Express Link, which facilitates the pooling of various devices, including AI accelerator chips, processors, and memory, for large data center operators. By enhancing the interoperability of these systems, Panmnesia aims to enable companies to efficiently harness and integrate a diverse array of system components, optimizing performance and resource utilization in high-capacity computing environments.

Brave Company

Series A in 2024
Brave Company is a wellness enterprise that develops and markets consumer health brands, focusing on convenient, nutritious products like chicken breast and diet foods. Their mission is to transform daily health habits by integrating their offerings into everyday routines, such as exercise, meals, and social activities. They achieve this by supporting and collaborating with creators through a platform that provides brand incubation, marketing support, personalized recommendations, performance analytics, and offline fitness facilities.

Kardome

Series A in 2024
Kardome develops real-time software that uses proprietary beamforming technology to isolate a user's voice and suppress background noise, enabling high-quality speech in environments with multiple speakers. The software can be integrated with existing microphone systems in consumer electronics and automotive infotainment, supporting voice-controlled devices, hands-free speakerphones, tablets, smartphones, and conference-call equipment. Founded in 2018 and headquartered in Mazor, Israel, Kardome aims to provide seamless voice control in acoustically challenging environments without requiring loud speech or close microphone proximity.

RideFlux

Series B in 2024
RideFlux is a South Korean self-driving software company focused on safe and reliable autonomous transportation. The firm develops autonomous driving software and pilot services, including remote vehicle control and high-precision map operation, to enable safe, efficient mobility. Founded in 2018, RideFlux conducts development and testing in Jeju Island, leveraging its varied road environments and weather conditions to advance urban autonomy. The company aims to provide integrated software and services that support autonomous driving for consumer and mobility services, emphasizing safety and reliability in autonomous transportation.

LESSENGERS

Series C in 2024
LESSENGERS specializes in the manufacturing of optical interconnect solutions that utilize polymer wires for optical waveguides in three-dimensional space. The company designs innovative products that facilitate cost-effective direct optical coupling without the need for lens optics. These solutions are particularly suited for data center applications, enabling the connection of two points requiring optical signal transmission in communication devices. By employing transparent polymer wires, LESSENGERS provides effective wiring options for optical transceiver modules and photonics devices. This technology helps companies enhance their communication products and deliver seamless network connectivity to their users.

MicrobiotiX

Series B in 2024
MicrobiotiX develops bacteriophage and microbiome-based therapeutics to combat multidrug-resistant infections and autoimmune diseases, and pursues therapeutic diagnostic technologies to enable microbiome-focused treatments. The company’s platform supports safe gastrointestinal microbiota transplant in a medical setting, formulates fecal microbiota transplant capsules for oral administration, and conducts research and development of bacteriophages, with the aim of delivering convenient, economical therapies that reduce infection risk. Through these approaches, MicrobiotiX seeks to advance microbiome and phage therapies for difficult-to-treat conditions, integrating diagnostics with therapeutics to streamline patient care.

Bio Design Lab

Series B in 2024
Bio Design Lab is a biotechnology company focused on the development of biopharmaceutical products, specifically in the areas of gene, cell, and immunotherapies. The company employs systems-level genetic and genomic design strategies to create potent drugs aimed at addressing a range of diseases. By utilizing advanced methodologies, Bio Design Lab aims to enhance the efficiency of drug development processes for healthcare organizations, ultimately contributing to the creation of effective therapeutic solutions.

FIRMMIT

Series B in 2024
FIRMMIT optimizes agricultural growth data through secure collection and analysis of ag-tech data, aiming to enhance crop yields and promote sustainable farming practices.

AIDIN ROBOTICS

Series B in 2024
AIDIN ROBOTICS is a developer of AI-driven sensors and robotic systems.

Wello

Series A in 2024
Wello is an API that offers a policy recommendation service for individuals and policy intelligence for businesses.

Wello

Series A in 2024
Wello is a government business solution that offers a natural language processing-based business recommendation-application-management service.

VUS

Seed Round in 2024
VUS is a public transportation company that offers traffic analysis, transportation card data analysis, and visualization services.

Allround Doctors

Series A in 2024
Allround Doctors is a digital healthcare startup that develops digital medical devices for cancer patients.

Building Care

Seed Round in 2024
Building Care is a technology company specializing in property management solutions. It develops a platform that connects buildings and their occupants, enhancing the quality of life for residents and workers. The platform offers features like a central communication hub, building maintenance tools, and event calendars, helping property managers streamline operations, save time and money, and improve overall tenant satisfaction.

Two Slash For

Seed Round in 2024
Two Slash For is a beauty brand that offers a wide variety of cosmetic products online.

Bitmagic

Seed Round in 2024
Bitmagic creates a game concept, and it builds a background story and creates an immersive 3D world.

Xpanner

Series B in 2024
Xpanner is a developer of a cloud-based construction management platform that integrates various construction technology products into a single solution. By streamlining disparate tools, Xpanner enables construction teams to access and manage data from one point, fostering collaboration among all stakeholders. This approach not only enhances productivity, with an average improvement of 15%, but also boosts management efficiency and safety on construction sites. Additionally, Xpanner's platform emphasizes environmental, social, and governance (ESG) improvements, making it a comprehensive solution for modern construction challenges.

Doers

Seed Round in 2024
Doers is an influencer commerce platform that offers several services for connecting influencers and companies.

Trenbe

Series E in 2024
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Founded in 2016, Trenbe focuses on footwear products while offering a diverse range of related fashion items to cater to its customers' needs.

Thorough Future

Series A in 2024
Thorough Future specializes in integrating advanced technology into medical care. It focuses on enhancing diagnostic services' accuracy and efficiency for clinical medicine and providing personalized treatment recommendations, particularly for cancer patients.

Twelve Labs

Series A in 2024
Twelve Labs offers a platform that empowers businesses and developers to analyze and interpret video content through multiple modalities like visual and auditory data. This enables the creation of intelligent video applications across industries such as technology, media, entertainment, and security.

CLAP

Series A in 2024
CLAP is a performance management platform focused on enhancing both individual and organizational growth. The company's integrated growth platform facilitates the alignment of employee goals, feedback, and performance, thereby enabling businesses to establish a robust performance management culture. CLAP offers solutions for regular performance management systems and effective onboarding programs, equipping organizations with the necessary tools for goal alignment and performance optimization. Additionally, the platform provides communication and leadership resources to support effective performance management practices.

Inter X

Series B in 2024
Inter X is an industrial AI and big data analysis company.

EYEQ Lab

Series B in 2024
EYEQ Lab is an engineering firm that develops and manufactures power semiconductors, offering end-to-end development and manufacturing capabilities for power semiconductor technologies. The company supports applications in solar energy, autonomous vehicles, high-speed charging, medical equipment, and aerospace. By applying specialized engineering expertise, EYEQ Lab aims to advance power system performance, efficiency, and reliability across customer projects.

LiveIn

Series B in 2024
LiveIn is a leading online marketplace specializing in student accommodation, boasting over 20,000 listings. The company operates a real estate brokerage platform designed to assist young individuals with limited economic resources in finding affordable rental housing. LiveIn prioritizes the well-being of its clients and workers, ensuring a responsible approach to their services. The platform provides a seamless rental search experience, featuring fully furnished rooms equipped with complimentary WiFi, weekly housekeeping, and maintenance services. This enables customers to easily locate and book rental properties in their vicinity, making the process efficient and user-friendly.

Over The Hand

Series A in 2024
Over The Hand is a technology company that specializes in creating immersive, realistic virtual characters. Their platform, a cross-verse system, enables users to design and interact with their own virtual avatars, combining augmented reality, virtual reality, and character play. This allows users to produce and engage with diverse content, fostering joy and inspiration through character-driven experiences.

Lillem

Series A in 2024
Lillem is a manufacturing company specializing in the research, development, and production of materials for lithium secondary batteries. It focuses on creating innovative pouch films that enhance battery performance, offering proprietary technology that boosts capacity and stability, ensuring high-performing and reliable batteries for its customers.

PersonaAI

Venture Round in 2024
PersonaAI is a conversational AI technology company that provides chatbot, callboat and AI semiconductor Kiosk product and SaaS products.

Meditherapy

Series A in 2024
Meditherapy is a retailer specializing in health and beauty products for the face and body. Its platform offers a range of skincare products, such as eye creams, wrinkle rollers, face masks, serums, and devices for skin toning and anti-aging, enabling customers to purchase all their skincare needs from one source and achieve professional-quality results at home.

LabInCube

Series A in 2024
LabInCube develops inCube materials capable of selective drug release, sustained release, and supporting complex raw materials.

Syntekabio

Post in 2024
Syntekabio, Inc. is a bioinformatics company based in Daejeon, South Korea, founded in 2009. The firm specializes in genome analysis and the integration of bio data, utilizing advanced algorithms to create personal genome maps that facilitate disease prevention and the development of customized medications. Syntekabio also offers a technology for collecting and integrating decrypted whole genome data, which is instrumental in analyzing diseases, including rare conditions. Their MAHA supercomputer significantly reduces data-processing costs and enhances genome-based diagnostics. The company focuses on gene-related research and technology development, leveraging a genome big data platform and artificial intelligence for drug development and genetic analysis.

StealthMole

Series A in 2024
StealthMole is an AI-powered dark web intelligence firm that specializes in monitoring cyber threats and detecting criminal activities. The company has developed a cybersecurity platform that harnesses artificial intelligence to identify compromised account credentials, gather threat information, and analyze relationships between data points. Additionally, StealthMole's platform provides visualization tools for investigations, allowing organizations to enhance their security measures and protect sensitive information effectively. Through its innovative approach, StealthMole aims to help businesses navigate the complexities of cybercrime and bolster their defenses against emerging threats.

Juexin Technology

Series B in 2024
Juexin Technology is an entity that designs high-speed optoelectronic chips. Its primary focus is on the development of electrical chips for high-speed optical communications.

Sionic AI

Seed Round in 2024
Sionic AI is a technology company that specializes in providing customizable artificial intelligence platforms for businesses. Its core offering is a large language model platform that enables companies to create AI agents capable of understanding and responding to text-based queries, summarizing and restructuring input, and learning from user feedback. This allows businesses to tailor AI services to their specific needs, aiding in decision-making, information analysis, and overall business management.

PulseSight Therapeutics

Seed Round in 2024
PulseSight Therapeutics is an ophthalmology-focused biotechnology company developing treatments for severe retinal diseases. It advances non-viral gene therapies delivered through minimally invasive methods to address blindness associated with retinal conditions. In addition, the company develops therapeutic proteins aimed at treating both short- and long-term retinal disorders, including chronic non-infectious uveitis, degenerative diseases, retinal vascular diseases, and macular edema. These approaches seek to improve ocular bioavailability and tolerability while supporting adherence to treatment. By focusing on therapies that preserve and improve vision, PulseSight aims to provide physicians and ophthalmologists with options that address unmet clinical needs and improve patient quality of life.

Noctua Games

Venture Round in 2024
Noctua Games develops the next level of mobile games, is an official platform from ATTN.

Open Asset

Seed Round in 2024
Open Asset specializes in developing blockchain-based technology for efficient issuance and management of token assets. They offer a comprehensive suite of services including a blockchain API, wallet, and advanced features tailored for enterprises aiming to deploy tokenized assets, thereby enhancing operational efficiency and fostering secure transactions.

Order of Meta

Seed Round in 2024
Order of Meta is a gaming studio focusing on the development of free-to-play mobile games. Comprising experienced creators who specialize in mid-core and hardcore genres, the company aims to produce engaging action games that introduce innovative metagame elements. With a mission to deliver fresh and thrilling experiences in the mobile gaming sphere, Order of Meta seeks to captivate players through familiar gameplay mechanics combined with novel features, particularly in the shooting game segment.

DYNE Medical Group

Series B in 2024
DYNE Medical Group is a medical equipment manufacturer specializing in endoscopy devices and artificial intelligence solutions for urological surgery. The company focuses on developing innovative manufacturing technologies that incorporate reusable flexible endoscopes, utilizing a unique optimization design and ultra-precision processing. This advanced approach aims to enhance the effectiveness of endoscopic procedures, facilitating minimally invasive treatments for patients. Additionally, DYNE Medical Group is committed to providing AI-based cancer diagnostics, further supporting healthcare professionals in delivering improved patient care.

​Orange Square

Series B in 2024
​Orange Square is a fintech platform that offers prepaid cards and mobile wallets for travelers.

Zendure

Series A in 2023
Zendure is a company specializing in innovative technology and sustainable energy solutions, focusing on consumer electronics that provide eco-friendly power options. The company has established itself as a leading manufacturer and retailer of products such as power banks, chargers, and energy storage systems. Its flagship product, the Balcony Energy Storage System, has successfully attracted 100,000 users in Europe, generating $70 million in revenue. Zendure's energy storage solutions allow consumers to efficiently store excess electricity generated by photovoltaic systems, significantly reducing their electricity bills. The company enjoys a strong market presence in Germany, France, and the Netherlands, with plans to expand into additional European markets. By offering plug-and-play solutions that require no complicated installation, Zendure aims to make clean energy accessible and practical for both on-grid and off-grid living.

Kek Entertainment

Seed Round in 2023
Kek Entertainment specializes in developing multiplayer mobile games.

Getcha

Series B in 2023
Getcha is a comprehensive car purchasing and rental service that operates an online comparison shopping platform. The company facilitates the buying process by connecting consumers with sellers and providing access to a network of dealerships. Getcha enables users to obtain multiple price quotes, ensuring transparency in transaction pricing. In addition to car purchases, the company offers long-term rentals, leasing options, test rides, and car consulting services, catering to a wide range of automotive needs. By streamlining the car buying experience, Getcha empowers customers with the information they need to make informed decisions while allowing sellers to focus on motivated buyers.

CareMedi

Series B in 2023
CareMedi is a healthcare company specializing in the development of innovative medical devices, particularly a wearable drug pump designed to enhance the quality of life for individuals with diabetes. The company's platform offers a range of healthcare products, including medical equipment, nebulizers, aspirators, and massagers. By enabling consumers to conveniently order these products from home, CareMedi aims to improve overall lifestyle and health outcomes for its users.

Twelve Labs

Seed Round in 2023
Twelve Labs offers a platform that empowers businesses and developers to analyze and interpret video content through multiple modalities like visual and auditory data. This enables the creation of intelligent video applications across industries such as technology, media, entertainment, and security.

The Grit

Series A in 2023
The Grit manufactures multi-use container and collection boxes.

Mardi Mercredi

Series A in 2023
Mardi Mercredi is a clothing retailer specializing in easy-to-wear everyday apparel for women, men, and children. The company offers a diverse range of products, including jackets, jeans, tops, shirts, and various accessories. Known for its French-inspired designs, Mardi Mercredi caters to the fashion needs of its customers by providing stylish and practical clothing options that reflect current trends while ensuring comfort and accessibility.

Brexogen

Series C in 2023
Brexogen is a biotechnology company focused on cell therapy research and development. It specializes in creating optimized parental cells for exosome production, aiming to treat incurable diseases through stem cell exosomes.

Petpharma

Series A in 2023
Petpharma is an Operator of an e-commerce platform intended to provide veterinary medicines.

Wello

Seed Round in 2023
Wello is a government business solution that offers a natural language processing-based business recommendation-application-management service.

FuriosaAI

Series C in 2023
FuriosaAI delivers the performance for real-time AI services while achieving energy efficiency for the lowest operation cost at scale. They build the entire product on a solid core foundation because AI chips on the ground are doomed to fail when it comes to addressing the complex and rapidly changing requirement metrics of hyper scalers and enterprises.

Indent

Series A in 2023
Indent is a provider of SPRAY, the Instagram affiliate marketing solution, for online shopping stores. It brings your customers' friends to your store and the average cost per this visit is only $1.

Camfit

Convertible Note in 2023
Camfit is a travel and leisure company focused on the Korean camping industry. It operates a platform that facilitates real-time reservations for camping sites, enhancing the camping experience for users. In addition to standard camping options, Camfit provides innovative experiences such as glamping, which caters to those seeking a more luxurious outdoor experience. The company also emphasizes community engagement and commerce, creating a comprehensive ecosystem for outdoor enthusiasts. By removing barriers to camping, Camfit enables families and individuals to enjoy nature in a convenient and accessible manner.

Biome ATS

Seed Round in 2023
BioM ATS intends to provide the fundamental infrastructure required to progress the complex strain design platform and foster technical collaboration with microbiome firms through proof-of-concept (POC) of the complex strain design technology. It is a strategy to begin the platform business in earnest by the end of the year, with an emphasis on platform advancement and collaboration with industry, academia, research institutes, and the military.

BiomATZ

Seed Round in 2023
BiomATZ is a biotechnology company focused on developing microbiome therapeutics through its proprietary platform. This innovative platform isolates and analyzes the complex interactions within gut microbiota to create cooperative microbial consortia. By leveraging a bank of intestinal microorganism strains, BiomATZ facilitates the identification of optimal functional strain combinations, which can enhance the efficacy of live biotherapeutic products. The company is dedicated to advancing personalized medicine and improving gut health solutions, with potential applications in pharmaceuticals, nutraceuticals, and functional foods. Through its research and development efforts, BiomATZ aims to contribute significantly to the field of microbiome science and its therapeutic applications.

Baskit

Seed Round in 2023
Baskit facilitates supply chains by offering commercial support and tools tailored for offline distribution businesses in Indonesia. Its platform addresses major challenges faced by millions of SMEs in the distribution chain, enhancing visibility, efficiency, and access to financing.

Thorough Future

Series A in 2023
Thorough Future specializes in integrating advanced technology into medical care. It focuses on enhancing diagnostic services' accuracy and efficiency for clinical medicine and providing personalized treatment recommendations, particularly for cancer patients.

infludeo

Series A in 2023
infludeo is a fan membership platform that connects global Kpop fans with Kpop artists.

Levit

Series B in 2023
Mobile commerce app that allows customers to have an enjoyable and affordable shopping experience

Diorigin

Seed Round in 2023
Diorigin is a comprehensive content IP holding company. It obtains original content IP and methodically develops and implements complete plans.

Jenfi

Funding Round in 2023
Jenfi is a financial technology company founded by Jeffrey Liu and Justin Louie, specializing in revenue-based financing for digital-native businesses in Southeast Asia. The company offers a service known as Growth Capital as a Service (GCaaS), which provides non-dilutive capital of up to US$1,000,000 to help businesses scale their marketing, inventory, and growth initiatives. Jenfi utilizes a proprietary risk assessment engine to evaluate both the creditworthiness of businesses and their marketing growth efficiency, ensuring that financing options are flexible and customized to meet the specific needs of each client. The platform has supported hundreds of digital-native companies, including various B2B and SaaS startups. Prior to founding Jenfi, Liu and Louie successfully developed and exited the fitness subscription service GuavaPass.

Lime AI

Seed Round in 2023
Lime provides professional stress management using AI

Xpanner

Series A in 2023
Xpanner is a developer of a cloud-based construction management platform that integrates various construction technology products into a single solution. By streamlining disparate tools, Xpanner enables construction teams to access and manage data from one point, fostering collaboration among all stakeholders. This approach not only enhances productivity, with an average improvement of 15%, but also boosts management efficiency and safety on construction sites. Additionally, Xpanner's platform emphasizes environmental, social, and governance (ESG) improvements, making it a comprehensive solution for modern construction challenges.

Vedanta Biosciences

Series E in 2023
Vedanta Biosciences is a clinical-stage microbiome company focused on developing therapies for immune-mediated and infectious diseases using live bacteria derived from the human microbiome. The company designs orally delivered defined bacterial consortia, leveraging libraries of microbiome-derived strains, proprietary datasets from human interventional studies, and tools for selecting potent strains. Its platform encompasses consortium design and CGMP manufacturing of bacterially defined products, enabling physicians to access live bacteria drugs for autoimmune and inflammatory conditions. Headquartered in Cambridge, Massachusetts, Vedanta Biosciences aims to create a new category of oral therapies arising from defined bacterial communities grown from clonal cell banks.

Cashwalk

Series A in 2023
Cashwalk is an app that incentivizes users to walk more by offering financial rewards. It provides a pedometer function and aims to promote healthier lifestyles, particularly for individuals managing chronic diseases like hypertension, hyperlipidemia, and diabetes.

S-Alpha Therapeutics

Series B in 2023
S-Alpha Therapeutics Inc. is a digital therapeutics company based in Seoul, South Korea, established in 2019. It specializes in researching and developing health applications and platform technologies that leverage digital devices for the treatment of various diseases. The company’s product pipeline includes SAT-001, an application focused on ophthalmology for eye disease treatment; SAT-002, which addresses neurological conditions; SAT-003, designed for oncology to support cancer patients in their recovery; and SAT-008, aimed at public crises to address social issues. In addition to its health applications, S-Alpha Therapeutics also develops therapeutic devices, striving to provide innovative solutions for unmet medical needs across multiple therapeutic areas, including ophthalmology, neuropsychiatry, and cancer.

Adler

Pre Seed Round in 2023
With lightweight and fast 3D engine, Adler’s 3D Web will usher into an era where virtual reality becomes an everyday part of life, accessible from anywhere in the world. Adler specializes in the 3D Web, offering its own 3D engine and programming language known as "Adler XRML." Based on Web, this engine guarantees seamless compatibility with PCs, mobile devices, Meta Quest, and Apple Vision Pro, without the hassle of separate app installations. Adler recently launched its own technology-driven social media platform. In 2022, Adler secured a significant investment of 2.1 million USD from prominent institutional investors, including Korea Investment Partners, the top-ranked investment firm in Korea based on AUM rankings, reaffirming its technological prowess. Last September, Adler took center stage as an official technology partner at the prestigious Carrousel du Louvre in Paris, France, during the Focus Art Fair. Yurica Ovaerenu, the CEO of Adler, embarked on her entrepreneurial journey at the age of 16 while studying in the second year of Seoul Science High School. She chose to drop out of Seoul National University, the top-ranked university in Korea. At the age of 27, she became a serial entrepreneur who underwent a gender transition. Inspired by her extensive experience playing 3D games like Overwatch and Mabinogi before her transition, she had a vision to create a virtual reality where individuals can truly be themselves.

DotDotDot

Venture Round in 2023
DotDotDot is a South Korean company founded in 2018, specializing in the creation of animated video content for social media platforms. Headquartered in Seoul, the company develops technology that enables users to enhance their communication by incorporating emotions into 3D backgrounds and characters. DotDotDot allows users to share stories through short-form video comics, facilitating a more engaging and interactive way to express ideas compared to traditional photo, video, and text-based social media formats. By focusing on user-generated content and innovative storytelling, DotDotDot aims to transform social interactions in the digital landscape.

Indent

Series A in 2023
Indent is a provider of SPRAY, the Instagram affiliate marketing solution, for online shopping stores. It brings your customers' friends to your store and the average cost per this visit is only $1.

Guhada

Series B in 2023
Guhada operates an online retail platform that serves as a distribution hub for luxury goods, connecting European boutiques with domestic markets, including shopping malls and fashion vertical commerce. The company specializes in supplying high-demand luxury items and contemporary products, offering a diverse selection of bags, clothing, shoes, and accessories for both men and women. Utilizing a blockchain-based e-commerce system, Guhada enables customers to access genuine luxury products at competitive prices, enhancing the shopping experience for those seeking premium fashion items.

TCab Tech

Seed Round in 2023
TCab Tech is building a air mobility ecosystem in order to provide the general public with zero-emission airborne ridesharing.

ENERZAi

Series A in 2023
ENERZAi is a Seoul-based artificial intelligence technology company that develops hardware- and software-enabled AI solutions. It provides MCU, CPU, and application processor services to enable AI on edge devices, including smart sensors, wearable devices, and robotics. The technology supports autonomous supervision, monitoring, and control of physical processes with real-time processing, and is designed to help customers migrate from expensive GPU instances by reducing model size, inference time, and operating costs. ENERZAi's offerings span software and lightweight hardware platforms for embedded applications in industrial, consumer, and automation contexts.

VSI

Series B in 2023
VSI is a semiconductor manufacturer specializing in automotive networking technologies. It develops essential semiconductors for next-generation automotive applications, focusing on products crucial to autonomous vehicle functionality.

Inter X

Venture Round in 2023
Inter X is an industrial AI and big data analysis company.

The Grim Entertainment

Seed Round in 2023
The Grim Entertainment is a publisher of webtoons, focusing on creating and distributing comic book content online.

S&E bio

Series A in 2022
S&E Bio is a biopharmaceutical company specializing in the development of cell therapies aimed at addressing neurological disorders. The company focuses on creating safe and effective treatments using stem cell-derived extracellular vesicles, particularly mesenchymal stem cell-derived therapeutics. S&E Bio targets a range of conditions, including acute stroke, moyamoya disease, chronic stroke, dementia, and cognitive disorders. Through its innovative approach to stem cell therapy, the company seeks to provide advanced treatment options for patients suffering from these incurable diseases, enhancing their quality of life and treatment outcomes.

Kneader

Series B in 2022
Kneader operates an online recruitment platform specializing in temporary and part-time job matching. It offers career management services for job seekers to create profiles highlighting their skills, education, and experience, and apply for jobs. Employers can post jobs, view candidate profiles, and hire candidates through the platform.

Value of Space

Series A in 2022
Value of Space develops an online platform that provides accurate and efficient property valuations for all types of real estate. Its system offers market value estimates through advanced automated valuation models, benefiting real estate market operators.

NRISE

Series B in 2022
NRISE is a company focused on developing innovative software applications that enhance communication and content sharing among users. It offers a range of services, including MOCI and WIPPY, which are designed to facilitate connections between individuals and provide access to diverse content. In addition to social media services, NRISE has created an application specifically for home workouts, integrating fitness with social interaction. Through these applications, the company aims to bring users the joy of communication while promoting engagement with various types of content.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.